Literature DB >> 1233251

Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization.

K E Andersson, L Nyberg, H Dencker, J Göthlin.   

Abstract

The absorption of digoxin has been studied in fasting patients undergoing transumbilical, portal catheterization for diagnostic purposes. A purely aqueous solution was administered orally in 4 patients and in the sigmoid colon in 2 patients. Blood samples were taken simultaneously from the portal and a peripheral vein. Plasma digoxin concentrations were determined by radioimmunoassay. Digoxin appeared early in the blood after oral administration; the average peak of porto-peripheral concentration differences was at 18 min. After intrasigmoid administration, absorption was slower, and no distinct peaks were found. Calculation of the mean amounts absorbed showed that half the dose had been absorbed via the portal vein during 2 hours in the oral study and during6 hours in the intrasigmoid test. Approximately 2/3 of the dose had been absorbed during 6 hours after oral dosing. The absorption rate was estimated taking into account the decreasing amount of drug left to be absorbed at different times. After cral administration, the mean peak rate was found to correspond to an absorption half-time of 0.78 h, which was more than 20 times faster than the rate after 6 h. The mean rate after intrasigmoid administration appeared to be about 1/3 of that after oral dosing. Physiological factors that might account for these differences in absorption rate are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233251     DOI: 10.1007/bf00613427

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Tritiated digoxin studies in human subjects.

Authors:  J E DOHERTY; W H PERKINS; G K MITCHELL
Journal:  Arch Intern Med       Date:  1961-10

2.  Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.

Authors:  L Nyberg; K E Andersson; A Bertler
Journal:  Acta Pharm Suec       Date:  1974-11

3.  Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.

Authors:  L Nyberg; L Bratt; A Forsgren; S Hugosson
Journal:  Acta Pharm Suec       Date:  1974-11

4.  Bioavailability of digoxin.

Authors:  A Bertler; A Redfors; S Medin; L Nyberg
Journal:  Lancet       Date:  1972-09-30       Impact factor: 79.321

5.  Pharmacokinetics of digoxin and its 4'''-acetyl- and methylderivates in the rat.

Authors:  N Rietbrock; U Abshagen; K von Bergmann; H Kewitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  [Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats].

Authors:  W Forth; E Furukawa; W Rummel
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

7.  Absorption rates of some cardiac glycosides and portal blood flow.

Authors:  A Haass; H Lüllmann; T Peters
Journal:  Eur J Pharmacol       Date:  1972-09       Impact factor: 4.432

8.  The absorption of orally administered (12 - 3 H)digoxin in man.

Authors:  B Beermann; K Hellström; A Rosén
Journal:  Clin Sci       Date:  1972-10       Impact factor: 6.124

9.  Absorption and transport of digitoxin in the dog.

Authors:  G C Oliver; J Cooksey; C Witte; M Witte
Journal:  Circ Res       Date:  1971-10       Impact factor: 17.367

10.  Intestinal absorption of six tritium-labeled digitalis glycosides in rats and guinea pigs.

Authors:  N J Greenberger; R P MacDermott; J F Martin; S Dutta
Journal:  J Pharmacol Exp Ther       Date:  1969-06       Impact factor: 4.030

View more
  12 in total

Review 1.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

2.  Intestinal absorption of zinc.

Authors:  C J Van den Hamer; H W Prins
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

3.  Influence of diet on digoxin dose requirements.

Authors:  J Turner; S M Dobbs; P W Nicholson; A P McGill; E M Rodgers
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

4.  The absorption of piretanide from the gastro-intestinal tract is site-dependent.

Authors:  D Brockmeier; H G Grigoleit; H Leonhardt
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Fasting and postprandial absorption of digoxin from a microencapsulated formulation.

Authors:  B Bergdahl; C Bogentoft; U E Jonsson; J O Magnusson
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Disease-related alterations in cardiac glycoside disposition.

Authors:  H R Ochs; D J Greenblatt; G Bodem; H J Dengler
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

7.  Evidence of nonlinearity in digoxin pharmacokinetics.

Authors:  J G Wagner; K D Popat; S K Das; E Sakmar; H Movahhed
Journal:  J Pharmacokinet Biopharm       Date:  1981-04

Review 8.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

9.  Some aspects of the intestinal absorption of zinc in man.

Authors:  K E Andersson; L Bratt; H Dencker; E Lanner
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

10.  Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing.

Authors:  K H Antonin; P Bieck; M Scheurlen; M Jedrychowski; H Malchow
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.